Computational modelling has been used to create dual-action compounds with exciting potential as new antibiotics.
The proof of principle experiment raises the possibility of new antibiotics that can target harmful bacteria on two fronts and consequently are less likely to be overcome by resistant strains.
The University of Leeds/John Innes Centre collaboration modelled potential new drugs based on the activity of thiophene compounds. These had previously shown promise as antibiotics before toxicity issues prevented them from going forward to human clinical trials.
Observing the activity of the thiophenes, the team computationally modelled new antibiotic candidates and then synthesised and tested them on pathogenic bacteria Escherichia coli (E. coli).
They found a series of biphenyl-based compounds inhibited the activity of the harmful bacteria by targeting two enzymes, DNA gyrase, and DNA topoisomerase IV, both of which are essential to bacterial survival.
“These novel compounds represent the start of a programme that could lead to a new series of antibiotics,” said Professor Tony Maxwell, of the John Innes Centre, and one of the authors of the study.
“The current programme represents a proof of principle, and this initial success suggests we will be able to discover even better antibiotic candidates going forward.” added first author of the study, University of Leeds researcher Dr Kyle Orritt. 23e o9
The researchers have already discussed the implications of the work with pharmaceutical companies, raising the possibility of a new source of antibiotics.
This work follows the discovery of a new possibility of exploiting the established antibacterial target DNA gyrase which offers a new medicinal chemistry strategy.
New antibiotics are urgently needed owing to the evolution of bacteria which are resistant to existing treatments. This problem of antimicrobial resistance (AMR) poses an enormous threat to human health due to an increase in the number of untreatable bacterial infections.
By 2050 it is predicted that AMR will be responsible for 10 million global deaths annually, more deaths than cancer and costing the world economy $100 trillion.
Original Article: Could cyber designs deliver potent dual-action antibiotics?
More from: University of Leeds | John Innes Centre
The Latest on: Dual-action antibiotics
- Colistin: An Update on the Antibiotic of the 21st Centuryon March 26, 2023 at 5:00 pm
In recent years, colistin has attracted considerable interest as an antibiotic for use against ... mechanisms of action and resistance, combination therapy and also its use for the treatment ...
- Insights into Antibiotic Resistance Through Metagenomic Approacheson March 23, 2023 at 5:00 pm
Insert length between 800 and 3000 bp. ‡‡ One clone was resistant to all three antibiotic classes in a secondary screen. The generic term 'antibiotic' is used to denote any class of organic ...
- Endolysin, a Solution to Antibiotic Resistanceon March 22, 2023 at 9:39 am
Antibiotic resistance is becoming common among all the bacterial species Bacteria like Staphylococcus aureus are notoriously known for their multiple resistance A chemical substance known as ...
- How long do antibiotics take to work?on March 22, 2023 at 1:15 am
IF you've been unlucky enough to pick up an infection, chances are you've been prescribed antibiotics. The life-saving pills are used by millions of people every year, for a whole host of issues.
- What You Should Eat During and After Antibioticson March 16, 2023 at 5:00 pm
Taking probiotics during and after a course of antibiotics may help support your digestion and reduce side effects including diarrhea. Eating high fiber and prebiotic foods may also help.
- Not enough new antibiotics in the pipeline, WHO review concludeson March 16, 2023 at 11:22 am
Only four of the 27 have new mechanisms of action, and most are not new drug classes, but evolution of existing classes." Currently, one antibiotic, Solithroymcin—to be used to treat community ...
- A quick new way to screen virus proteins for antibiotic propertieson March 13, 2023 at 2:49 pm
A whole new world of antibiotics is waiting inside the viruses that infect bacteria. Scientists are making it easier to study them.
- High-throughput genetic screening approach to study antibiotic proteins made by bacteriophageson March 12, 2023 at 5:00 pm
As conventional antibiotics continue to lose effectiveness ... battles based on genomic sequence alone or study them in action because many bacteria can't be cultured in a lab – and even if ...
- Do Antibiotics Affect Birth Control?on March 11, 2023 at 4:00 pm
You may have heard that if you take antibiotics with your hormonal birth control (pills, patches, shots, implants, or vaginal rings) it can raise your chance of getting pregnant. With one ...
- Top antibiotic expert nearly died from cut while gardeningon March 3, 2023 at 2:05 pm
A top antibiotic expert says he nearly died after ... He said that he finally took action following the 2018 incident after his infectious disease colleagues became concerned at the state of ...
via Bing News
The Latest on: Dual-action antibiotics
[google_news title=”” keyword=”dual-action antibiotics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News